Knockdown of CETN1 inhibits breast cancer cells proliferation

J BUON. 2014 Jul-Sep;19(3):656-61.

Abstract

Purpose: Breast cancer is a multifactorial disease and identification of the genes and proteins regulating breast carcinogenesis is critical in exploring novel targeted therapies. The aim of this study was to investigate the role CETN1 in breast cancer growth and metastasis.

Methods: CETN1 expression levels were measured in breast tissue samples by immunohistochemistry (IHC). We selected high CETN1-expressing cell lines from human breast carcinoma cells with metastatic potential. The proliferation of cells was evaluated by MTS assay. Changes in progression of cell division were assessed by cell cycle analysis. Changes in CETN1 levels in breast tumor cells were analysed by Western blot.

Results: Our results demonstrated that overexpression of CETN1 occurred mainly in breast cancer cells in which CETN1 expression was low. Knockdown of CETN1 by lentivirus- shRNA significantly inhibited breast cancer cells' proliferation, growth and metastasis.

Conclusion: CETN1 is overexpressed in breast cancer tissue and promotes cells'proliferation, tumor growth and metastasis.

MeSH terms

  • Animals
  • Breast Neoplasms / pathology
  • Calcium-Binding Proteins / physiology*
  • Cell Cycle
  • Cell Cycle Proteins / physiology*
  • Cell Line, Tumor
  • Cell Proliferation*
  • Female
  • Humans
  • Mice
  • RNA Interference
  • Rats
  • Rats, Inbred Lew

Substances

  • CETN1 protein, human
  • Calcium-Binding Proteins
  • Cell Cycle Proteins